Immunogenicity and safety of influenza vaccination in cancer patients receiving checkpoint inhibitors targeting PD-1 or PD-L1

Affiliations

• ¹ Department of Drug Development/DITEP, Gustave Roussy Cancer Institute, Villejuif, France.
• ² Department of Cancer Medicine, Gustave Roussy Cancer Institute, Chevilly-Larue, France.
• ³ INSERM U932, Paris Sciences et Lettres University, Curie Institute, Paris, France.
• ⁴ Department of International Patients Cancer Care.
• ⁵ Ambulatory Cancer Care.
• ⁶ Cancer Medicine, Gustave Roussy Cancer Institute, Villejuif, France.
• ⁷ Department of Medical Oncology, Antony Private Hospital, Antony, France.
• ⁸ Department of Medical Oncology, Foch Hospital, Suresnes, France.
• ⁹ Department of Infectious Diseases, Hôtel-Dieu Teaching Hospital, Paris, France.
• ¹⁰ Ambulatory Cancer Care. Electronic address: [email protected].